EC Number |
Inhibitors |
Structure |
---|
3.2.2.22 | ((5-(2-amino-4,6-dihydroxy-5-pyrimidinyl)pentanoyl)amino)acetic acid |
- |
|
3.2.2.22 | (E)-3-(5-methylfuran-2-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)prop-2-enamide |
CID 16271106, a group III compound, dose-dependent inhibition of ricin activity, mildly or moderately cytotoxic |
|
3.2.2.22 | 2,2-dimethyl-4-[(E)-2-phenylethenyl]-2,3-dihydro-1H-1,5-benzodiazepine |
- |
|
3.2.2.22 | 2-(methylsulfonyl)-1-(naphthalen-1-ylmethyl)-1H-benzimidazole |
- |
|
3.2.2.22 | 2-amino-1,4-dihydro-6-hydroxy-4-oxo-5-pyrimidinepentanoic acid |
- |
|
3.2.2.22 | 2-amino-1,4-dihydro-6-hydroxy-4-oxo-a-phenyl-pyrimidinepentanoic acid |
PPA |
|
3.2.2.22 | 2-amino-4-oxo-3,4-dihydro-pteridine 7-carbohydrazide |
35% inhibition at 0.5 mM |
|
3.2.2.22 | 2-methylsulfonyl-1-(naphthalen-1-ylmethyl)benzimidazole |
CID 18576762, a group III compound, dose-dependent inhibition of ricin activity, mildly or moderately cytotoxic |
|
3.2.2.22 | 2-[(E)-[(5-methylthiophen-2-yl)methylidene]amino]-N-phenylbenzamide |
- |
|
3.2.2.22 | 4,6-bis(propan-2-ylamino)-1,3,5-triazine-2-carbonitrile |
CID 644401, a group III compound, dose-dependent inhibition of ricin activity, mildly or moderately cytotoxic |
|